Oncogenic ASPM Is a Regulatory Hub of Developmental and Stemness Signaling in Cancers

Despite recent advances in molecularly targeted therapies and immunotherapies, the effective treatment of advanced-stage cancers remains a largely unmet clinical need. Identifying driver mechanisms of cancer aggressiveness can lay the groundwork for the development of breakthrough therapeutic strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Kelvin K., Bae, Byoung-Il, Hsu, Chung-Chi, Cheng, Li-Hsin, Shaked, Yuval
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502471/
https://www.ncbi.nlm.nih.gov/pubmed/37384617
http://dx.doi.org/10.1158/0008-5472.CAN-23-0158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502471/
https://www.ncbi.nlm.nih.gov/pubmed/37384617
http://dx.doi.org/10.1158/0008-5472.CAN-23-0158

Ejemplares similares